Germany excels in Acute lymphoblastic leukemia (ALL) treatment, with top hospitals like Asklepios Hospital Barmbek, Düsseldorf Clinics Association, and Asklepios St. Georg Hospital. Accredited by the German Cancer Society (DKG), these centers offer advanced therapies and expert care. Innovative procedures include CAR T-cell therapy, targeted therapy, stem cell transplantation, and monoclonal antibody therapy, contributing to a high survival rate of 90%.
Asklepios Hospital Barmbek treats 80,000 patients annually, while Düsseldorf Clinics Association provides care to over 200,000 patients with a team of 60+ professors. Asklepios St. Georg Hospital, part of Asklepios Kliniken, treats 87,000 patients annually, maintaining high medical standards.